Latest News for: CSL

Edit

CSL Roundup: Chengdu Rongcheng clings to top spot

China.dot.org 21 Mar 2026
BEIJING, March 21 (Xinhua) -- The third round of the 2026 Chinese Super League concluded Saturday with a dramatic 3-3 draw between Chongqing Tonglianglong and Chengdu Rongcheng in a key clash in the title race ... But the hosts' joy was short-lived.
Edit

Blood Plasma Centers Move Into More Middle-Class Neighborhoods

New York Times 20 Mar 2026
Across the United States, plasma centers are opening in wealthier areas as more people struggle with the high cost of housing, groceries and health care ... .
Edit

CSL Earns Montreal’s Top Employer Recognition for Eighth Year Running

Nasdaq Globe Newswire 17 Mar 2026
MONTREAL, March 17, 2026 (GLOBE NEWSWIRE) -- For the eighth year in ...
Edit

Our Commitment to the Hemophilia B Community: An Update on HEMGENIX® (etranacogene dezaparvovec-drlb) Availability (CSL Limited)

Public Technologies 17 Mar 2026
CSL is currently experiencing a temporary global stockout of HEMGENIX® that will result in delays in treatment for some individuals in countries with established commercial access ... https.//www.csl.com/contact.
Edit

CSL roundup: Shandong wipes out points deficit with win over Guoan

China.dot.org 15 Mar 2026
BEIJING, March 15 (Xinhua) -- Shandong Taishan erased its six-point disciplinary deduction after just two rounds of the 2026 Chinese Super League season, beating Beijing Guoan 2-1 at home in a highly anticipated clash on Saturday ... Enditem .
Edit

Audenz (CSL Seqirus) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, & Forecasts, 2020-2025, ...

Nasdaq Globe Newswire 13 Mar 2026
.
Edit

Alburx (CSL Behring) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, ...

Nasdaq Globe Newswire 13 Mar 2026
The alburx market is poised for growth through increased trauma care, liver disease treatments, and demand for plasma products ... .
Edit

CSL announces expansion of Illinois plasma therapy manufacturing facility

Herald & Review - Decatur 10 Mar 2026
New $1.5 billion investment builds on over $3 billion already spent on CSL's U.S. operations since 2018 ... .
Edit

Albuminar (CSL Behring) Market Research Report 2026: Epidemiology, Competitive Landscape, Pipeline Analysis, Market Insights & ...

Nasdaq Globe Newswire 10 Mar 2026
.
Edit

CSL Breaks Ground on $1.5B Biopharmaceutical Manufacturing Expansion in Kankakee, Illinois

Construction Review Online 10 Mar 2026
building and construction information from America, Europe, Asia and Africa .
Edit

Humate-P (CSL Behring) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, & Forecasts, 2020-2025, ...

Nasdaq Globe Newswire 10 Mar 2026
North America shows rapid growth potential ... North America shows rapid growth potential. .
Edit

Corifact (CSL Behring) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, ...

Nasdaq Globe Newswire 10 Mar 2026
Asia-Pacific presents significant growth potential, and there is rising demand for biological products in the Corifact market ... .
Edit

Afluria (CSL Seqirus) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, ...

Nasdaq Globe Newswire 10 Mar 2026
.
Edit

CSLLY - Books will close today, March 10, 2026 (CSL Limited)

Public Technologies 10 Mar 2026
CSL Limited published this content on March 10, 2026, and is solely responsible ...
Edit

CSL Seqirus Signs Long-Term Agreement with The Pan American Health Organization (PAHO) to Advance Regional Influenza Protection in the Region of the Americas (CSL Limited)

Public Technologies 10 Mar 2026
Developing influenza vaccines across all age groups in expanded markets is a strategic priority for CSL Seqirus ... About CSL Seqirus. CSL Seqirus is part of CSL (ASX.CSL) ... For more information about CSL Seqirus, visit CSL.com ... CSL Seqirus.

Article Search

tools
×
×
×
×